Summary of Purpose
This study is designed to determine the safety, pharmacokinetics and pharmacodynamics of a single intravenous dose of TS23 in healthy adults.Read More →
The following dates are available for this trial. Trial information last updated on 20 December 2016.
|1 Jul 2015||11 Nov 2016||1 Jun 2016||1 Jun 2017||1 Dec 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All